Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.
about
Lorcaserin for overweight or obese adultsLorcaserin for overweight or obese adultsHydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesityNeuroinflammatory basis of metabolic syndromePhospholipase C-related catalytically inactive protein can regulate obesity, a state of peripheral inflammation.Protective effects of silymarin against bisphenol A-induced hepatotoxicity in mouse liver.Effects of infant weight gain on subsequent allergic outcomes in the first 3 years of life.Obesity and microbiota: an example of an intricate relationship.Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J miceAnti-Saccharomyces cerevisiae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study.Gastrointestinal morbidity in obesity.DNA methylation modifications associated with chronic fatigue syndrome.Low-grade dietary-related inflammation and survival after colorectal cancer surgery.Unraveling the complex relationship triad between lipids, obesity, and inflammationBiochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice.Antioxidant and associated capacities of Camu camu (Myrciaria dubia): a systematic review.Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity.Application of multiplex arrays for cytokine and chemokine profiling of bileInflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC CohortNon-alcoholic fatty liver disease, diet and gut microbiota.Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population.Red cell distribution width in type 2 diabetic patientsHigh-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.Clinical Relevance of Transforming Growth Factor-β1, Interleukin-6 and Haptoglobin for Prediction of Obesity Complications in Prepubertal Egyptian ChildrenEffect of Acupuncture on Body Weight Reduction and Inflammatory Mediators in Egyptian Obese PatientsDynamics of biomarkers in relation to aging and mortality.Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines.Immunometabolism in obese asthmatics: are we there yet?Vitamin D status and circulating biomarkers of endothelial dysfunction and inflammation in non-diabetic obese individuals: a pilot study.Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study.Obesity and cytokines in childhood-onset systemic lupus erythematosus.Non-alcoholic fatty liver disease: a diabetologist's perspective.Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.Tumour necrosis factor-α inhibition with lenalidomide alleviates tissue oxidative injury and apoptosis in ob/ob obese mice.Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.Physiological Effects Associated with Quinoa Consumption and Implications for Research Involving Humans: a Review.Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.Body Mass Index as a Measure of Obesity: Racial Differences in Predictive Value for Health Parameters During Pregnancy.iNOS inhibition improves autonomic dysfunction and oxidative status in hypertensive obese rats.Pro-inflammatory cytokines mediate GPCR dysfunction.
P2860
Q24186092-50588AC2-8764-4345-927C-AB6B83126B8AQ24188095-B6D3363E-7DC0-4DF8-9CB8-87745E21D118Q26749072-31104E70-9C84-44D3-9B0B-8A703E6DA819Q26852584-EB4DA88C-7C0B-4292-8A42-26863FAE5925Q33560216-A3F98D97-E6DF-40E2-BD21-C582D9F71EE2Q33598219-7A7A5D1F-391C-41EB-A8E6-B819459E4613Q33759547-AAC29176-3601-44AA-9D35-71970C7F444CQ33805550-350A9857-7DEE-4853-A87C-077AC31BB27AQ33825040-21ADBE77-0E43-4B0C-9A14-27A16B332732Q33908808-ADD7FA79-20BD-404B-98A7-50A5F97D34B3Q34006048-F2A80BF2-A1DF-4CA1-9307-AB52977F632BQ34027879-58B20D4C-E945-4611-9F0A-453F9D94C941Q34038212-9E982E9D-0A99-43D2-980F-E2A2353669A1Q34042152-262EE751-B106-48E5-B0DF-B2BC55B240F5Q34072214-07508151-672C-4F1B-8EF4-E332158D9D2FQ34976833-49B72404-84BE-44EB-8E50-0938422F2D22Q35176319-26D3062B-330F-48EB-BA60-BDAA21447B37Q35242261-B9BA8C77-E300-4BA9-BD2B-E5592383AC8CQ35680361-C53FC6FE-5DC7-46A4-B7F3-F468D5F7EC9CQ35728214-45004C98-5F76-46E6-A8EA-5D124C3B1738Q35743078-20A74F4A-D3DE-4882-868A-EFD42D19F760Q36253207-C659C01F-7585-4641-B7D2-EB09692C14AFQ36289672-AABE521D-C619-4852-A827-E14BD512F772Q36929032-B696D415-9043-4D04-BC78-215DF79C25E6Q36929124-93CA5E1C-A7B7-4D8C-B7F1-34EE0ECCCF11Q36984319-07747D78-7A96-452D-BBDC-E5BD48040FE7Q37207028-E50F0AED-0BB1-4683-81EB-143F74EFAB71Q37235370-9873886F-3FE3-4165-B51B-354B77954411Q37549359-F873DF62-55FD-4981-B2FE-76B14AF79F49Q37579475-51269A07-B86E-4E77-A9C0-32C17338A429Q37704576-B296A916-B34B-46F7-9AE7-19DF00E5A89EQ38167264-A71903F0-06AA-4608-8D6A-76560B4E6133Q38254986-2C008AAB-1F3E-4136-AFD1-AC82655282B6Q38307733-FF0F1BCA-1211-4B21-A507-BB035432C0BEQ38380655-7E5B2FBA-995C-48B2-8CDD-F15B317C5402Q38561953-608DE039-25E2-4779-8F10-2B5DEEE7863CQ38741861-CDFCF996-7059-4DC3-9838-717D97AB513BQ38917157-962F7F28-B306-48FC-91B8-BFA52A7DCA7EQ39038552-B7C636E0-FB36-41D5-9C7A-D164ECD5206FQ39070066-A3624E89-0BEE-46D4-9B5A-3FE9E26CD74D
P2860
Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.
@en
type
label
Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.
@en
prefLabel
Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.
@en
P2093
P2860
P356
P1476
Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.
@en
P2093
Gabriela Rodríguez-Ramírez
Heriberto Rodríguez-Hernández
Luis E Simental-Mendía
Miguel A Reyes-Romero
P2860
P304
P356
10.1155/2013/678159
P577
2013-04-17T00:00:00Z